GE HealthCare Technologies Inc. $GEHC Shares Sold by Voya Investment Management LLC

Voya Investment Management LLC trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 131,286 shares of the company’s stock after selling 15,839 shares during the period. Voya Investment Management LLC’s holdings in GE HealthCare Technologies were worth $9,860,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in GE HealthCare Technologies by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after purchasing an additional 703,903 shares during the period. Dodge & Cox lifted its stake in shares of GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after purchasing an additional 6,982,441 shares in the last quarter. State Street Corp grew its stake in shares of GE HealthCare Technologies by 1.9% in the second quarter. State Street Corp now owns 19,660,742 shares of the company’s stock valued at $1,456,271,000 after buying an additional 372,755 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of GE HealthCare Technologies by 2.0% in the second quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock valued at $881,060,000 after buying an additional 231,302 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of GE HealthCare Technologies during the 2nd quarter valued at about $468,120,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 0.7%

GEHC opened at $83.32 on Wednesday. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The stock has a market capitalization of $37.95 billion, a PE ratio of 17.21, a P/E/G ratio of 3.50 and a beta of 1.10. The firm’s fifty day moving average price is $78.15 and its 200 day moving average price is $75.62.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. The company had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on GEHC shares. Stifel Nicolaus set a $90.00 price target on GE HealthCare Technologies in a report on Friday, November 21st. Barclays started coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price for the company. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Morgan Stanley boosted their price objective on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a report on Thursday, October 30th. Finally, Wells Fargo & Company lowered their target price on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday, October 30th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $87.09.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.